Glucagon‐like peptide‐1 receptor agonists and mental health: A meta‐analysis of randomized controlled trials
Giovanni Antonio Silverii, Christian Marinelli, Edoardo Mannucci, Francesco Rotella
Abstract
GAS has received financial support and speaking fees from Astra Zeneca, Eli Lilly and Novo Nordisk outside the present paper; EM has received speaking fees from Astra Zeneca, Eli Lilly, Merck, Novo Nordisk and Sanofi, research grants from Eli Lilly and Novo Nordisk, outside the present paer; CM and FR have no conflict of interest to declare. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.15538. The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials. Data S1. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.